Elevation of oxidative-damage biomarkers during aging in F2 hybrid mice: Protection by chronic oral intake of resveratrol

Free Radical Biology and Medicine

Volumn 46, Issue 6, 2009, Pages 799-809

  Wong, Yee Ting ^a,b   Gruber, Jan ^b   Jenner, Andrew M ^b   Ng, Mary Pei Ern ^b   Ruan, Runsheng ^a,b   Tay, Francis Eng Hock ^a,b  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

8 Hydroxy 2 deoxyguanosine; Aging; Free radicals; Hybrid mice; Isoprostane; Oxidative damage; Protein carbonyl; Resveratrol

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTAGLANDIN F2 ALPHA; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; LIPID; RESVERATROL;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DNA DAMAGE; MOUSE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; URINE LEVEL;

ADMINISTRATION, ORAL; AGING; ANIMALS; BIOLOGICAL MARKERS; BREEDING; DEOXYGUANOSINE; DNA DAMAGE; KIDNEY; MICE; MYOCARDIUM; ORGAN SPECIFICITY; OXIDATIVE STRESS; PROSTAGLANDINS A; PROTEIN CARBONYLATION; STILBENES;

MUS; RICE STRIPE VIRUS;

EID: 60449091285     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.12.016     Document Type: Article

References (110)

1. Gescher A.J., and Steward W.P. Relationship between mechanisms, bioavailability, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 953-957
2. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discovery 5 (2006) 493-506
3. Renaud S., and de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339 (1992) 1523-1526
4. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., and Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
5. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., and Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430 (2004) 686-689
6. Valenzano D.R., Terzibasi E., Genade T., Cattaneo A., Domenici L., and Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol. 16 (2006) 296-300
7. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., and Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
8. Collins J.J., Evason K., and Kornfeld K. Pharmacology of delayed aging and extended lifespan of Caenorhabditis elegans. Exp. Gerontol. 41 (2006) 1032-1039
9. Viswanathan M., Kim S.K., Berdichevsky A., and Guarente L. A role for SIR-2.1 regulation of ER stress response genes in determining C. elegans life span. Dev. Cell 9 (2005) 605-615
10. Anekonda T.S. Resveratrol-a boon for treating Alzheimer's disease?. Brain Res. Rev. 52 (2006) 316-326
11. Goldberg D.M., Yan J., and Soleas G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 36 (2003) 79-87
12. Walle T., Hsieh F., DeLegge M.H., Oatis Jr. J.E., and Walle U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 32 (2004) 1377-1382
13. Asensi M., Medina I., Ortega A., Carretero J., Bano M.C., Obrador E., and Estrela J.M. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic. Biol. Med. 33 (2002) 387-398
14. Sale S., Verschoyle R.D., Boocock D., Jones D.J., Wilsher N., Ruparelia K.C., Potter G.A., Farmer P.B., Steward W.P., and Gescher A.J. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene. Br. J. Cancer 90 (2004) 736-744
15. Orallo F., Alvarez E., Camina M., Leiro J.E.M., Gomez E., and Fernandez P. The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol. Pharmacol. 61 (2002) 294-302
16. Turrens J.F., Lariccia J., and Nair M.G. Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats. Free Radic. Res. 27 (1997) 557-562
17. Miura D., Miura Y., and Yagasaki K. Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sci. 73 (2003) 1393-1400
18. Wenzel E., Soldo T., Erbersdobler H., and Somoza V. Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol. Nutr. Food Res. 49 (2005) 482-494
19. Sener G., Tugtepe H., Yuksel M., Cetinel S., Gedik N., and Yegen B.C. Resveratrol improves ischemia/reperfusion-induced oxidative renal injury in rats. Arch. Med. Res. 37 (2006) 822-829
20. Beckman K.B., and Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78 (1998) 547-581
21. Harman D. Free radical theory of aging: an update. Increasing the functional life span. Ann. N. Y. Acad. Sci. 1067 (2006) 10-21
22. Muller F.L., Lustgarten M.S., Jang Y., Richardson A., and Van Remmen H. Trends in oxidative aging theories. Free Radic. Biol. Med. 43 (2007) 477-503
23. Sohal R.S., and Weindruch R. Oxidative stress, caloric restriction, and aging. Science 273 (1996) 59-63
24. Pamplona R., and Barja G. Mitochondrial oxidative stress, aging and caloric restriction: the protein and methionine connection. Biochim. Biophys. Acta 1757 (2006) 496-508
25. Brunet-Rossinni A.K. Reduced free-radical production and extreme longevity in the little brown bat (Myotis lucifugus) versus two non-flying mammals. Mech. Ageing Dev. 125 (2004) 11-20
26. Barja G., and Herrero A. Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J. 14 (2000) 312-318
27. Herrero A., and Barja G. Sites and mechanisms responsible for the low rate of free radical production of heart mitochondria in the long-lived pigeon. Mech. Ageing Dev. 98 (1997) 95-111
28. Orr W.C., and Sohal R.S. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263 (1994) 1128-1130
29. Melov S., Ravenscroft J., Malik S., Gill M.S., Walker D.W., Clayton P.E., Wallace D.C., Malfroy B., Doctrow S.R., and Lithgow G.J. Extension of life-span with superoxide dismutase/catalase mimetics. Science 289 (2000) 1567-1569
30. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M., Coskun P.E., Ladiges W., Wolf N., Van Remmen H., Wallace D.C., and Rabinovitch P.S. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308 (2005) 1909-1911
31. Feng R., He W., and Ochi H. A new murine oxidative stress model associated with senescence. Mech. Ageing Dev. 122 (2001) 547-559
32. Das N., Levine R.L., Orr W.C., and Sohal R.S. Selectivity of protein oxidative damage during aging in Drosophila melanogaster. Biochem. J. 360 (2001) 209-216
33. Ishii N., Goto S., and Hartman P.S. Protein oxidation during aging of the nematode Caenorhabditis elegans. Free Radic. Biol. Med. 33 (2002) 1021-1025
34. Siomek A., Gackowski D., Rozalski R., Dziaman T., Szpila A., Guz J., and Olinski R. Higher leukocyte 8-oxo-7,8-dihydro-2′-deoxyguanosine and lower plasma ascorbate in aging humans?. Antioxid. Redox Signaling 9 (2007) 143-150
35. de Magalhaes J.P., and Church G.M. Cells discover fire: employing reactive oxygen species in development and consequences for aging. Exp. Gerontol. 41 (2006) 1-10
36. Gruber J., Schaffer S., and Halliwell B. The mitochondrial free radical theory of ageing-where do we stand?. Front. Biosci. 13 (2008) 6554-6579
37. Andziak B., O'Connor T., Qi W., DeWaal E., Pierce A., Chaudhuri A., Van R., and Buffenstein R. High oxidative damage levels in the longest-living rodent, the naked mole-rat. Aging Cell 5 (2006) 463-471
38. Golden T.R., Hierfield D.A., and Melov S. Oxidative stress and aging: beyond correlation. Aging Cell 1 (2002) 117-123
39. Sohal R.S., and Weindruch R. Oxidative stress, caloric restriction, and aging. Science 273 (1996) 59-63
40. Weindruch R., and Walford R. The Retardation of Aging and Disease by Dietary Restriction (1988), Thomas, Springfield, IL
41. Masoro E.J. Subfield history: caloric restriction, slowing aging, and extending life. Sci. Aging Knowledge Environ. 2003 (2003) RE2
42. Miller R.A., and Nadon N.L. Principles of animal use for gerontological research. J. Gerontol. A Biol. Sci. Med. Sci. 55 (2000) B117-B123
43. Miller R.A. Biomarkers of aging: prediction of longevity by using age-sensitive T-cell subset determinations in a middle-aged, genetically heterogeneous mouse population. J. Gerontol. A Biol. Sci. Med. Sci. 56 (2001) B180-B186
44. Miller R.A., Austad S., Burke D., Chrisp C., Dysko R., Galecki A., Jackson A., and Monnier V. Exotic mice as models for aging research: polemic and prospectus. Neurobiol. Aging 20 (1999) 217-231
45. Soleas G.J., Yan J., and Goldberg D.M. Ultrasensitive assay for three polyphenols (catechin, quercetin and resveratrol) and their conjugates in biological fluids utilizing gas chromatography with mass selective detection. J. Chromatogr. B Biomed. Sci. Appl. 757 (2001) 161-172
46. ESCODD, Gedik C.M., and Collins A. Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB J. 19 (2005) 82-84
47. Wong Y.T., Ruan R., and Tay F.E. Relationship between levels of oxidative DNA damage, lipid peroxidation and mitochondrial membrane potential in young and old F344 rats. Free Radic. Res. 40 (2006) 393-402
48. Morrow J.D., and Roberts L.J. 2nd. The isoprostanes: current knowledge and directions for future research. Biochem. Pharmacol. 51 (1996) 1-9
49. Jenner A., Ren M., Rajendran R., Ning P., Huat B.T., Watt F., and Halliwell B. Zinc supplementation inhibits lipid peroxidation and the development of atherosclerosis in rabbits fed a high cholesterol diet. Free Radic. Biol. Med. 42 (2007) 559-566
50. Halliwell B., and Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br. J. Pharmacol. 142 (2004) 231-255
51. Miller R.A., Austad S., Burke D., Chrisp C., Dysko R., Galecki A., Jackson A., and Monnier V. Exotic mice as models for aging research: polemic and prospectus. Neurobiol. Aging 20 (1999) 217-231
52. Catalano K.J., Bergman R.N., and Ader M. Increased susceptibility to insulin resistance associated with abdominal obesity in aging rats. Obes. Res. 13 (2005) 11-20
53. Asghar M., and Lokhandwala M.F. Antioxidant tempol lowers age-related increases in insulin resistance in Fischer 344 rats. Clin. Exp. Hypertens. 28 (2006) 533-541
54. Fraga C.G., Shigenaga M.K., Park J.W., Degan P., and Ames B.N. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. USA 87 (1990) 4533-4537
55. Kaneko T., Tahara S., and Matsuo M. Non-linear accumulation of 8-hydroxy-2′-deoxyguanosine, a marker of oxidized DNA damage, during aging. Mutat. Res. 316 (1996) 277-285
56. Izzotti A., Cartiglia C., Taningher M., De Flora S., and Balansky R. Age-related increases of 8-hydroxy-2′-deoxyguanosine and DNA-protein crosslinks in mouse organs. Mutat. Res. 446 (1999) 215-223
57. Sai K., Takagi A., Umemura T., Hasegawa R., and Kurokawa Y. Changes of 8-hydroxydeoxyguanosine levels in rat organ DNA during the aging process. J. Environ. Pathol. Toxicol. Oncol. 11 (1992) 139-143
58. Hudson E., Hogue B., Souza-Pinto N., Croteau D., Anson R., Bohr V., and Hansford R. Age-associated change in mitochondrial DNA damage. Free Radic. Res. 29 (1998) 573-579
59. Anson R.M., Senturker S., Dizdaroglu M., and Bohr V.A. Measurement of oxidatively induced base lesions in liver from Wistar rats of different ages. Free Radic. Biol. Med. 27 (1999) 456-462
60. Collins A.R., Cadet J., Moller L., Poulsen H.E., and Vina J. Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells?. Arch. Biochem. Biophys. 423 (2004) 57-65
61. Hamilton M.L., Guo Z., Fuller C.D., Van Remmen H., Ward W.F., Austad S.N., Troyer D.A., Thompson I., and Richardson A. A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA. Nucleic Acids Res. 29 (2001) 2117-2126
62. Gedik C.M., and Collins A. Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB J. 19 (2005) 82-84
63. Hamilton M.L., Van Remmen H., Drake J.A., Yang H., Guo Z.M., Kewitt K., Walter C.A., and Richardson A. Does oxidative damage to DNA increase with age?. Proc. Natl. Acad. Sci. USA 98 (2001) 10469-10474
64. Suh J.H., Wang H., Liu R.M., Liu J., and Hagen T.M. (R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis. Arch. Biochem. Biophys. 423 (2004) 126-135
65. Sohal R.S., Agarwal S., Candas M., Forster M.J., and Lal H. Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech. Ageing Dev. 76 (1994) 215-224
66. Barja G. Rate of generation of oxidative stress-related damage and animal longevity. Free Radic. Biol. Med. 33 (2002) 1167-1172
67. Armstrong P.J., and Lund E.M. Changes in body composition and energy balance with aging. Vet. Clin. Nutr. 3 (1996) 83-87
68. McGahon B.M., Murray C.A., and Horrobin D.F. Lynch. Age-related changes in oxidative mechanisms and LTP are reversed by dietary manipulation. Neurobiol. Aging 20 (1999) 643-653
69. Delachambre M.C., Narce M., Asdrubal P., and Poisson J.P. Changes in tissue polyunsaturated fatty acids with age, in spontaneously hypertensive rats. Lipids 33 (1998) 795-801
70. Morrow J.D. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab. Rev. 32 (2000) 377-385
71. Stadtman E.R. Role of oxidant species in aging. Curr. Med. Chem. 11 (2004) 1105-1112
72. Stadtman E.R., and Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab. Rev. 30 (1998) 225-243
73. Murali G., and Panneerselvam C. Age-associated oxidative macromolecular damages in rat brain regions: role of glutathione monoester. J. Gerontol. A Biol. Sci. Med. Sci. 62 (2007) 824-830
74. Rabek J.P., Boylston III W.H., and Papaconstantinou J. Carbonylation of ER chaperone proteins in aged mouse liver. Biochem. Biophys. Res. Commun. 305 (2003) 566-572
75. de Santi C., Pietrabissa A., Mosca F., and Pacifici G.M. Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica 30 (2000) 1047-1054
76. De Santi C., Pietrabissa A., Spisni R., Mosca F., and Pacifici G.M. Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica 30 (2000) 857-866
77. Goldberg D.M., Tsang E., Karumanchiri A., Diamandis E., Soleas G., and Ng E. Method to assay the concentrations of phenolic constituents of biological interest in wines. Anal. Chem. 68 (1996) 1688-1694
78. Kaeberlein M., McDonagh T., Heltweg B., Hixon J., Westman E.A., Caldwell S.D., Napper A., Curtis R., DiStefano P.S., Fields S., Bedalov A., and Kennedy B.K. Substrate-specific activation of sirtuins by resveratrol. J. Biol. Chem. 280 (2005) 17038-17045
79. Borra M.T., Smith B.C., and Denu J.M. Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 280 (2005) 17187-17195
80. Harikumar K.B., and Aggarwal B.B. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7 (2008) 1020-1035
81. Shankar S., Singh G., and Srivastava R.K. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front. Biosci. 12 (2007) 4839-4854
82. Pirola L., and Frojdo S. Resveratrol: one molecule, many targets. IUBMB Life 60 (2008) 323-332
83. Rahman I., Biswas S.K., and Kirkham P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 72 (2006) 1439-1452
84. Shih A., Davis F.B., Lin H.Y., and Davis P.J. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J. Clin. Endocrinol. Metab. 87 (2002) 1223-1232
85. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., and Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127 (2006) 1109-1122
86. Barger J.L., Kayo T., Vann J.M., Arias E.B., Wang J., Hacker T.A., Wang Y., Raederstorff D., Morrow J.D., Leeuwenburgh C., Allison D.B., Saupe K.W., Cartee G.D., Weindruch R., and Prolla T.A. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One 3 (2008) e2264
87. Robb E.L., Winkelmolen L., Visanji N., Brotchie J., and Stuart J.A. Dietary resveratrol administration increases MnSOD expression and activity in mouse brain. Biochem. Biophys. Res. Commun. 372 (2008) 254-259
88. Zamora-Ros R., Andres-Lacueva C., Lamuela-Raventos R.M., Berenguer T., Jakszyn P., Martinez C., Sanchez M.J., Navarro C., Chirlaque M.D., Tormo M.J., Quiros J.R., Amiano P., Dorronsoro M., Larranaga N., Barricarte A., Ardanaz E., and Gonzalez C.A. Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Br. J. Nutr. 100 (2007) 188-196
89. Penumathsa S.V., Koneru S., Samuel S.M., Maulik G., Bagchi D., Yet S.F., Menon V.P., and Maulik N. Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor. Free Radic. Biol. Med. 45 (2008) 1027-1034
90. Penumathsa S.V., Thirunavukkarasu M., Koneru S., Juhasz B., Zhan L., Pant R., Menon V.P., Otani H., and Maulik N. Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J. Mol. Cell. Cardiol. 42 (2007) 508-516
91. Thirunavukkarasu M., Penumathsa S.V., Koneru S., Juhasz B., Zhan L., Otani H., Bagchi D., Das D.K., and Maulik N. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic. Biol. Med. 43 (2007) 720-729
92. Gresele P., Pignatelli P., Guglielmini G., Carnevale R., Mezzasoma A.M., Ghiselli A., Momi S., and Violi F. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J. Nutr. 138 (2008) 1602-1608
93. Meng X., Maliakal P., Lu H., Lee M.J., and Yang C.S. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem. 52 (2004) 935-942
94. Burkon A., and Somoza V. Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides-two novel resveratrol metabolites in human plasma. Mol. Nutr. Food Res. 52 (2008) 549-557
95. Wen X., and Walle T. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab. Dispos. 34 (2006) 1786-1792
96. Bertelli A., Bertelli A.A., Gozzini A., and Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp. Clin. Res. 24 (1998) 133-138
97. 14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 72 (2003) 2219-2233
98. Monks T.J., and Lau S.S. The pharmacology and toxicology of polyphenolic-glutathione conjugates. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 229-255
99. Crowell J.A., Korytko P.J., Morrissey R.L., Booth T.D., and Levine B.S. Resveratrol-associated renal toxicity. Toxicol. Sci. 82 (2004) 614-619
100. Juan M.E., Vinardell M.P., and Planas J.M. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr. 132 (2002) 257-260
101. Reagan-Shaw S., Nihal M., and Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 22 (2008) 659-661
102. Boocock D.J., Faust G.E., Patel K.R., Schinas A.M., Brown V.A., Ducharme M.P., Booth T.D., Crowell J.A., Perloff M., Gescher A.J., Steward W.P., and Brenner D.E. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1246-1252
103. Haneke, K. E.; Carson, B. L.; Gregorio, C. A.; Hardy, R.; Belue, N. S. Review of toxicological literature for resveratrol prepared for Scott Masten, National Institute of Environmental Health Sciences (NIEHS). Submitted by Integrated Laboratory Systems, Inc., through NIEHS Contract N01-ES-6540; 2002.
104. Castello L., Froio T., Cavallini G., Biasi F., Sapino A., Leonarduzzi G., Bergamini E., Poli G., and Chiarpotto E. Calorie restriction protects against age-related rat aorta sclerosis. FASEB J. 19 (2005) 1863-1865
105. Zheng J., Mutcherson II R., and Helfand S.L. Calorie restriction delays lipid oxidative damage in Drosophila melanogaster. Aging Cell 4 (2005) 209-216
106. Masoro E.J. Overview of caloric restriction and ageing. Mech. Ageing Dev. 126 (2005) 913-922
107. Bua E., McKiernan S.H., and Aiken J.M. Calorie restriction limits the generation but not the progression of mitochondrial abnormalities in aging skeletal muscle. FASEB J. 18 (2004) 582-584
108. Gredilla R., Sanz A., Lopez-Torres M., and Barja G. Caloric restriction decreases mitochondrial free radical generation at complex I and lowers oxidative damage to mitochondrial DNA in the rat heart. FASEB J. 15 (2001) 1589-1591
109. 2 production and oxidative damage. Cardiovasc. Res. 74 (2007) 456-465
110. Ingram D.K., Zhu M., Mamczarz J., Zou S., Lane M.A., Roth G.S., and deCabo R. Calorie restriction mimetics: an emerging research field. Aging Cell 5 (2006) 97-108